OR WAIT null SECS
March 12, 2025
Video
In this video, part 2 of a 5-part series, panelists discuss unmet needs in pediatric food allergy research and clinical care.
March 10, 2025
Cianferoni discusses how pollen food allergy syndrome contributes to eosinophilic esophagitis (EoE) and potential management strategies.
At AAAAI 2025, Cianferoni described molecular mechanisms of pollen food allergy syndrome.
March 07, 2025
HCPLive spoke with Anagnostou at AAAAI on how to determine what food allergy treatment patients should undergo.
March 06, 2025
Article
This February 2025 month in review covers key updates in allergy, including advancements in immunotherapy and new insights on food allergy desensitization.
March 03, 2025
A phase 2 trial found that 100% of children on peanut oral immunotherapy tolerated 9043 mg of peanuts, vs 10% in the avoidant group.
Although omalizumab demonstrated superiority over oral immunotherapy, the treatments had comparable effectiveness when excluding dropouts from the analysis, Wood said at AAAAI.
March 02, 2025
HCPLive spoke with Cohen about how patients with a peanut allergy responded to oral immunotherapy with autoclaved peanuts.
March 01, 2025
HCPLive spoke with Warren at AAAAI 2025 about a pilot study showing allergen-free food subscriptions reduced healthcare use but lacked significance.
February 28, 2025
Stallergenes Greer announced that Palforzia is now available for children under 4 years old with a peanut allergy, which follows the extended indication approval in July 2024.